68 related articles for article (PubMed ID: 9120948)
21. Fatal liver complications with flutamide.
Osculati A; Castiglioni C
Lancet; 2006 Apr; 367(9517):1140-1. PubMed ID: 16616550
[No Abstract] [Full Text] [Related]
22. Fulminant liver failure associated with flutamide therapy for hirsutism.
Andrade RJ; Lucena MI; Fernández MC; Suárez F; Montero JL; Fraga E; Hidalgo F
Lancet; 1999 Mar; 353(9157):983. PubMed ID: 10459914
[No Abstract] [Full Text] [Related]
23. Hepatotoxicity with flutamide.
Karaahmet F; Kurt K
Fertil Steril; 2012 Nov; 98(5):e27; author reply e28. PubMed ID: 22985946
[No Abstract] [Full Text] [Related]
24. [Hirsutism, flutamide and hepatotoxicity].
Ruiz-Rebollo M; Atienza-Sánchez R; López-García E
Gastroenterol Hepatol; 2001 Apr; 24(4):218. PubMed ID: 11333662
[No Abstract] [Full Text] [Related]
25. Long-term, low-dose flutamide does not cause hepatotoxicity in hyperandrogenic women.
Legro RS
Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):188-9. PubMed ID: 16932279
[No Abstract] [Full Text] [Related]
26. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
[TBL] [Abstract][Full Text] [Related]
27. Hepatic failure with flutamide.
Kackar RR; Desai HG
Indian J Gastroenterol; 2003; 22(4):149-50. PubMed ID: 12962443
[TBL] [Abstract][Full Text] [Related]
28. Bicalutamide-associated fulminant hepatic failure.
Chodak GW
Urology; 1997 Dec; 50(6):1027. PubMed ID: 9426744
[No Abstract] [Full Text] [Related]
29. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen.
Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
Hepatology; 2004 Dec; 40(6):1361-9. PubMed ID: 15565568
[TBL] [Abstract][Full Text] [Related]
30. Male breast adenocarcinoma in a prostate cancer patient following prolonged anti-androgen monotherapy.
Karamanakos P; Mitsiades CS; Lembessis P; Kontos M; Trafalis D; Koutsilieris M
Anticancer Res; 2004; 24(2C):1077-81. PubMed ID: 15154626
[TBL] [Abstract][Full Text] [Related]
31. The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer.
Cherrier MM; Rose AL; Higano C
J Urol; 2003 Nov; 170(5):1808-11. PubMed ID: 14532781
[TBL] [Abstract][Full Text] [Related]
32. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.
Ibáñez L; Jaramillo A; Ferrer A; de Zegher F
Hum Reprod; 2005 Jul; 20(7):1833-6. PubMed ID: 15802316
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of stutter priapism with an antiandrogen.
Costabile RA
Tech Urol; 1998 Sep; 4(3):167-8. PubMed ID: 9800902
[TBL] [Abstract][Full Text] [Related]
34. Testosterone suppression in men with prostate cancer is associated with increased arterial stiffness.
Dockery F; Bulpitt CJ; Agarwal S; Rajkumar C
Aging Male; 2002 Dec; 5(4):216-22. PubMed ID: 12630068
[TBL] [Abstract][Full Text] [Related]
35. Use of antiandrogens as therapy for women with polycystic ovary syndrome.
Moghetti P
Fertil Steril; 2006 Jul; 86 Suppl 1():S30-1. PubMed ID: 16798285
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic options for drug induced liver injury: the efficacy of UDCA based on EBM].
Matsuzaki Y; Nishikawa K
Nihon Shokakibyo Gakkai Zasshi; 2003 Jun; 100(6):659-66. PubMed ID: 12833859
[No Abstract] [Full Text] [Related]
37. Combined androgen blockade-induced anemia in prostate cancer patients without bone involvement.
Bogdanos J; Karamanolakis D; Milathianakis C; Repousis P; Tsintavis A; Koutsilieris M
Anticancer Res; 2003; 23(2C):1757-62. PubMed ID: 12820454
[TBL] [Abstract][Full Text] [Related]
38. Long-term safety and tolerability of flutamide for the treatment of hirsutism.
Castelo-Branco C; Moyano D; Gómez O; Balasch J
Fertil Steril; 2009 Apr; 91(4):1183-8. PubMed ID: 18339379
[TBL] [Abstract][Full Text] [Related]
39. [Low-dose flutamide in the treatment of hyperandrogenism in adolescents].
Pizzo A; Borrielli I; Mastroeni MT; Fattori A; Dugo C; Dugo N; Dinatale A
Minerva Pediatr; 2008 Dec; 60(6):1357-66. PubMed ID: 18971896
[TBL] [Abstract][Full Text] [Related]
40. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
